Development of miR-92a inhibitors for the treatment of cardiovascular disease
- Funding ID
81X2200122
- Project number
116
- Institution
- Johann Wolfgang Goethe-Universität Frankfurt am Main - Klinikum - Medizinische Klinik III
- Project leader
- Stefanie Dimmeler
- Site
- RheinMain
- Short description
-
Based on own preliminary works that show that miR-92a inhibitors can improve cardiac function after infarction, the safety and optimisation studies necessary for an application in human …
Based on own preliminary works that show that miR-92a inhibitors can improve cardiac function after infarction, the safety and optimisation studies necessary for an application in human beings are to be carried out in the context of the application. For this, the composition of the microRNA inhibitors is to be optimised and the necessary pharmacological and toxicological examinations are to be performed.
- Project type
- Translational Research Project
- Funding
- € 2.457.576,20
- Begin
- 01.02.2015
- End
- 31.12.2019